Five Science Books About Cells and Genes, and the Order to Read Them

Most popular biology books do one of two things. They explain how something works, or they tell the story of the people who worked it out. The five below manage both, and between them they cover most of what a curious reader needs to follow the news about gene therapy, cancer drugs, cell lines or stem cells without feeling lost by the second paragraph.
Three of the five are by the same author. That sounds like a lack of range, but Siddhartha Mukherjee, a cancer physician and researcher at Columbia University, wrote them as a loose set: one on cancer, one on heredity, one on the cell. Each stands on its own, and together they give you a long view of modern medicine from three different windows. The other two, by Walter Isaacson and Rebecca Skloot, fill gaps that Mukherjee covers only briefly.
We picked these from what the books cover, how they have held up with scientists and teachers, and how published reviews received them. None of them is a textbook. All of them can be read in short sittings.
The five at a glance
| Book | Author | First published | What it is about |
|---|---|---|---|
| The Song of the Cell | Siddhartha Mukherjee | 2022 | Cells, from the first microscopes to cell therapies |
| The Gene: An Intimate History | Siddhartha Mukherjee | 2016 | Heredity, DNA and genetic medicine |
| The Code Breaker | Walter Isaacson | 2021 | CRISPR gene editing and the scientists behind it |
| The Immortal Life of Henrietta Lacks | Rebecca Skloot | 2010 | HeLa cells, consent and one family's story |
| The Emperor of All Maladies | Siddhartha Mukherjee | 2010 | The history of cancer and its treatment |
The order below is a reading order, not a ranking and not the order the books came out. It starts with the smallest living unit, moves to the instructions inside it, then to the tools for changing those instructions, and ends with the disease that taught medicine the most about cells going wrong.
1. Start with the cell: The Song of the Cell
Mukherjee's most recent book takes the cell as its subject and builds outward. It opens with the microscope makers of the 1600s who first saw cells, moves through the 19th-century idea that every living thing is made of cells and that every cell comes from another cell, and then visits the cells that matter most in medicine: the fertilized egg, blood cells, immune cells, nerve cells. The later chapters turn to medicine that treats cells as the drug itself, such as bone marrow transplants and engineered immune cells.
The writing moves between history, lab science and patients from the author's own practice. Some readers find the detours long. The payoff is that by the end, "cell therapy" stops being a phrase and becomes something you can picture.
Who it suits: readers who want the big frame before the details, and anyone who has read about stem cells or immune therapies and wanted to know what a cell is actually doing in there.
Read alongside: our explainer on what makes a stem cell a stem cell, which covers the self-renewal and specialization ideas the book returns to again and again.
2. Then the instructions: The Gene: An Intimate History
The Gene came out six years before The Song of the Cell, but it reads well second. It follows heredity from Gregor Mendel's pea plants and Charles Darwin through the eugenics movement (a dark chapter the book does not skip), the double helix, the cracking of the genetic code, recombinant DNA, the Human Genome Project and the first attempts at gene therapy.
Running through it is the author's own family history of mental illness, which turns abstract questions about inheritance into personal ones. What can a gene predict? What should a family want to know? That thread is why many readers remember this one most.
PBS turned the book into a two-part documentary in 2020, with Ken Burns as an executive producer. The film is a good way in if you want a preview, though the book goes far deeper.
Who it suits: people who enjoyed school genetics but lost the thread after Punnett squares, and anyone weighing what genetic tests or embryo screening can and cannot tell you who wants the history behind the debate.
What to read first: nothing is required, but the molecular middle section moves quickly. If the step from DNA to protein feels rushed, our mRNA explainer walks through transcription and translation slowly, and the chapters make more sense afterward.
3. Bring it up to date: The Code Breaker
Walter Isaacson, best known for his biographies of Albert Einstein and Steve Jobs, wrote this one about Jennifer Doudna, the Berkeley biochemist who, with Emmanuelle Charpentier, showed in 2012 that a bacterial defense system called CRISPR-Cas9 could be programmed to cut DNA at a chosen spot. The two shared the 2020 Nobel Prize in Chemistry for that work.
It is a biography first, so the science arrives through people. You get the race to publish, the long patent dispute with the Broad Institute of MIT and Harvard, the 2018 announcement by He Jiankui that he had edited the genomes of twin girls, and the ethical arguments that followed. A late section covers how Doudna's colleagues turned to COVID-19 testing in 2020.
One thing to keep in mind: the book went to press before the FDA approved the first CRISPR-based therapy, Casgevy, for sickle cell disease in December 2023. Read the forward-looking chapters as a snapshot of 2020 and 2021, not as the current state of the field.
Who it suits: readers who prefer people and rivalries to diagrams, and anyone curious about how science actually competes, through priority, patents and prizes.
4. Anywhere in the sequence: The Immortal Life of Henrietta Lacks
This is probably the book on the list that turns up most often on school and college reading lists, and it fits wherever you like. Rebecca Skloot tells the story of Henrietta Lacks, a Black mother of five treated for cervical cancer at Johns Hopkins in 1951. Cells from her tumor were taken without her knowledge and became HeLa, the first human cells to keep dividing indefinitely in the lab. HeLa went on to be used in testing the polio vaccine in the 1950s and in an enormous range of research since.
Much of the book follows Skloot's years of getting to know the Lacks family, especially Henrietta's daughter Deborah, who spent her life trying to understand what had happened to her mother. It is as much about trust, race and medicine as about cell biology.
The story kept moving after publication. In 2013 the NIH reached an agreement with the family on how researchers can access HeLa genome data. HBO released a film adaptation in 2017, and in 2023 the family settled a lawsuit with a biotechnology company that had sold HeLa cells.
Who it suits: readers drawn to ethics and people more than to molecular detail, book clubs, and students meeting cell culture for the first time.
Read alongside: our explainer on induced pluripotent stem cells. Today's iPS cell lines are made from donated skin or blood under detailed consent forms, and comparing that process with what happened in 1951 is a useful exercise.
5. When you are ready for a long one: The Emperor of All Maladies
Mukherjee's first book is a history of cancer, from descriptions in ancient medical texts through radical surgery, the first chemotherapy for childhood leukemia in the late 1940s, the link between smoking and lung cancer, the US National Cancer Act of 1971 and the targeted drugs of the 1990s and 2000s. It won the 2011 Pulitzer Prize for General Nonfiction, and PBS adapted it as a three-part series in 2015.
It is the longest of the five and the one most worth pacing. It is also a history, not a guide to treatment, and cancer care has changed considerably since 2010. Immunotherapies and engineered cell treatments have arrived since then; the first CAR-T therapy, Kymriah, was approved by the FDA in 2017. Our CAR-T explainer picks up roughly where the book leaves off.
Who it suits: readers who want to understand why progress against cancer has come in steps rather than a single cure, and people with a personal connection to the disease who find history steadier ground than statistics. Anyone facing treatment decisions should take their questions to their own care team, not to a history book.
If you only have time for one
- For the widest overview of modern biology: The Song of the Cell.
- For heredity, genetic testing and family history: The Gene.
- For understanding gene editing headlines: The Code Breaker.
- For research ethics and consent: The Immortal Life of Henrietta Lacks.
- For cancer and the long history of its treatment: The Emperor of All Maladies.
Getting more out of them
Read the three Mukherjee books in any order and you will meet the same scientists more than once, sometimes from a different angle. Keep a short list of names and dates on a card or in the back of the book. By the third book that list becomes a timeline of modern biology, which is more useful than any single chapter.
Pair each book with one primary source. For The Code Breaker, that might be the Nobel Prize website's page on the 2020 chemistry prize. For Henrietta Lacks, the NIH's own account of the HeLa genome agreement. Seeing how the official record describes an event the author dramatized sharpens your sense of what a narrative book can and cannot tell you.
When a chapter leans on an idea you only half remember, such as how a gene becomes a protein or why a mutation in one cell can matter, stop and look it up before pushing on. Ten minutes with a clear diagram of transcription and translation makes the second half of The Gene far easier, and the same diagram will carry you through the gene therapy chapters of The Song of the Cell.
This explainer is general information, not medical advice. Decisions about treatment, donation or trials belong with a clinician who knows your history.



